title: Percutaneous pulmonary valve implantation after endocarditis of Contegra® valved conduit: a case report.
abstract: This report describes the case of a 13-year-old boy with endocarditis of a Contegra® pulmonary valved conduit used for the correction of tetralogy of Fallot. He had severe pulmonary stenosis after endocarditis resolution. We performed percutaneous pulmonary valve implantation with resolution of the conduit dysfunction. The procedure was well tolerated by our patient and offered many advantages.
authors.affiliation: Department of Clinical Medicine and Cardiovascular Sciences, Adult and Pediatric Cardiac Surgery, University of Naples Federico II, Naples, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Palma
authors.forename: R
authors.initials: R
authors.lastname: Giordano
authors.forename: V
authors.initials: V
authors.lastname: Russolillo
authors.forename: C
authors.initials: C
authors.lastname: Vosa
mesh_terms: D000293:Adolescent; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001705:Bioprosthesis / Q000009:adverse effects*; D001807:Blood Vessel Prosthesis / Q000009:adverse effects*; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects* / Q000295:instrumentation; D006328:Cardiac Catheterization; D002417:Cattle; D004697:Endocarditis, Bacterial / Q000382:microbiology / Q000628:therapy*; D058834:Gemella / Q000302:isolation & purification; D006083:Graft Occlusion, Vascular / Q000209:etiology / Q000628:therapy; D006350:Heart Valve Prosthesis / Q000009:adverse effects*; D019918:Heart Valve Prosthesis Implantation / Q000009:adverse effects* / Q000295:instrumentation; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D011474:Prosthesis Design; D016459:Prosthesis-Related Infections / Q000382:microbiology / Q000628:therapy*; D011664:Pulmonary Valve / Q000601:surgery*; D013771:Tetralogy of Fallot / Q000601:surgery; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents